How European BioTech is Changing Cancer Care
Roundtable episode
Key points:
Bridging the gap between scientific breakthroughs and real-world cancer care remains one of Europe's biggest challenges
Sustainable, microalgae-based biomanufacturing could become a serious alternative for producing antibodies and other biologics
Moving cell therapy from highly personalised treatments to scalable, "off-the-shelf" solutions is key to reaching far more patients
AI and generative chemistry open up RNA as a drug target that traditional discovery has struggled to reach Europe excels at world-class research, but scaling BioTech companies still faces…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.